Saturday, May 20, 2017 12:28:46 AM
Sure, share prices have swung even on the very well-substantiated sellers in Canada, but a license for a 50k sqft facility with ties to Israeli products is very favourable.... To think AMS will be a leader in the space with such a facility is ludicrous -- but to think of it as an acquisition target / a definitive catalyst toward a far stronger valuation here is common sense. Imo!....
I have held Canadian cannabis stock since the first one IPO'd in 2014.... BLDV gets AMS in conjunction with its existing partners.... See ya later.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM